Francisco de Asis Ayala De La Peña-rekin lankidetzan egindako argitalpenak (14)

2023

  1. Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO study

    PLoS ONE, Vol. 18, Núm. 5 May

  2. Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells

    Frontiers in Molecular Biosciences, Vol. 10

2022

  1. A prognostic model to identify short survival expectancy of medical oncology patients at the time of hospital discharge

    ESMO Open, Vol. 7, Núm. 1

2021

  1. Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy

    npj Breast Cancer, Vol. 7, Núm. 1

2019

  1. SEOM clinical practice guideline: management and prevention of febrile neutropenia in adults with solid tumors (2018)

    Clinical and Translational Oncology, Vol. 21, Núm. 1, pp. 75-86

2018

  1. Estoicismo frente al cáncer: riesgo o protección

    Psicooncología: investigación y clínica biopsicosocial en oncología, Vol. 15, Núm. 1, pp. 11-22

  2. Key points to optimizing management and research on cancer-associated thrombosis

    Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 119-126

2017

  1. Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: The EPIPHANY Index

    British Journal of Cancer, Vol. 116, Núm. 8, pp. 994-1001

  2. Psychometric properties of Liverpool Stoicism Scale (LSS) in a cohort of patients with resected cancer in adjuvant treatment

    Anales de psicología, Vol. 33, Núm. 3, pp. 621-629

  3. The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score

    Clinical and Translational Oncology, Vol. 19, Núm. 9, pp. 1084-1090

2016

  1. On the necessity of new decision-making methods for cancer-associated, symptomatic, pulmonary embolism

    Thrombosis Research, Vol. 143, pp. 76-85

2015

  1. Should anticoagulation therapy be withheld in patients with active cancer after 6 months of low-molecular weight heparin?

    Journal of Clinical Oncology

2013

  1. CircRNAs: esponjas moleculares de microRNAs, ¿futuro terapéutico en cáncer?

    Eubacteria, Núm. 32

  2. Stress-induced hyperglycemia is a valuable biomarker in febrile neutropenia

    Revista Brasileira de Hematologia e Hemoterapia